You just read:

Inovio and QIAGEN Establish Collaboration to Develop Diagnostic Test for VGX-3100, Inovio's Novel Immunotherapy Targeting Advanced Cervical Pre-Cancer

News provided by

Inovio Pharmaceuticals, Inc.

May 16, 2019, 16:02 ET